arrow
返回

Bispecific Complement Engagers for Targeted Complement Activation

delete2023-08-01
delete6
PRE
AI
D
Dennis Pedersen
H
Heidi Gytz
M
Mikael Winkler
A
Alessandra Zarantonello
N
Niklas Baumann
A
Annette G. Hansen
S
Steffen Thiel
G
G.R. Andersen
T
Thomas Valerius
N
N.S. Laursen *
DOI:10.4049/jimmunol.2200952delete
delete原文链接
delete原文求助
delete分享
delete收藏
摘要

摘要

En 中文
Activation of the complement system represents an important effector mechanism of endogenous and therapeutic Abs. However, efficient complement activation is restricted to a subset of Abs due to the requirement of multivalent interactions between the Ab Fc regions and the C1 complex. In the present study, we demonstrate that Fc-independent recruitment of C1 by modular bispecific single-domain Abs that simultaneously bind C1q and a surface Ag can potently activate the complement system. Using Ags from hematological and solid tumors, we show that these bispecific Abs are cytotoxic to human tumor cell lines that express the Ag and that the modular design allows a functional exchange of the targeting moiety. Direct comparison with clinically approved Abs demonstrates a superior ability of the bispecific Abs to induce complement-dependent cytotoxicity. The efficacy of the bispecific Abs to activate complement strongly depends on the epitope of the C1q binding Ab, demonstrating that the spatial orientation of the C1 complex upon Ag engagement is a critical factor for efficient complement activation. Collectively, our data provide insight into the mechanism of complement activation and provide a new platform for the development of immunotherapies.
Keyword:
CHRONIC LYMPHOCYTIC-LEUKEMIA
MONOCLONAL-ANTIBODIES
ENGINEERED ANTIBODIES
EFFECTOR MECHANISMS
REGULATORY PROTEINS
CLASSICAL PATHWAY
EXPRESSION LEVELS
CD38 EXPRESSION
CD20 ANTIBODY
IN-VITRO

期刊

Journal of Immunology 封面图
Journal of Immunology
IF:
3.4
论文数:
3.7W
被引数:
9.9W

机构

U
university of kiel
学者数:
2.3W
论文数: 1.8W
被引数: 15
A
Aarhus University
学者数:
4.3W
论文数: 4.2W
被引数: 4.8W
引用论文

引用论文

err分享
err收藏
Framework for Loop-Free Convergence Using the Ordered Forwarding Information Base (oFIB) Approach
err
IF0
err2013-07-01
err0
PREAI
errM. Shand; S. Bryant; S. Previdi; C. Filsfils; P. Francois; O. Bonaventure
err分享
err收藏
Studying Cancer Heterogeneity by Single-Cell RNA Sequencing
err2019-02-19
err0
PREAI
errJohannes W. Bagnoli; Lucas E. Wange; Aleksandar Janjic; Wolfgang Enard
err分享
err收藏
Service-innovation capability founded on knowledge from customers
err2019-02-07
err0
PREAI
errHumaira Yasmeen; Ying Wang; Hashim Zameer; Abdul Waheed
err分享
err收藏
Context-dependent roles of complement in cancer补体在癌症中的上下文依赖作用
err2019-10-30
err239
errOAAI
errRoumenina, Lubka T.; Daugan, Marie V.; Petitprez, Florent; Sautes-Fridman, Catherine; Fridman, Wolf Herman
err分享
err收藏
Effects of aging on T cell function
err2009-08-01
err201
errOAAI
errHaynes, Laura; Maue, Alexander C.
err分享
err收藏
Antibody Distance from the Cell Membrane Regulates Antibody Effector Mechanisms抗体与细胞膜的距离调节抗体效应机制
err2017-05-15
err103
errOAAI
errCleary, Kirstie L. S.; Chan, H. T. Claude; James, Sonja; Glennie, Martin J.; Cragg, Mark S.
err分享
err收藏
Complement-dependent tumor cell lysis triggered by combinations of epidermal growth factor receptor antibodies
err2008-07-01
err164
errOAAI
errDechant, Michael; Weisner, Wencke; Berger, Sven; Peipp, Matthias; Beyer, Thomas; Schneider-Merck, Tanja; van Bueren, Jeroen J. Lammerts; Bleeker, Wim K.; Parren, Paul W. H. I.; van de Winkel, Jan G. J.; Valerius, Thomas
err分享
err收藏
In vivo targeting of human neutralizing antibodies against CD55 and CD59 to lymphoma cells increases the antitumor activity of rituximab
err2007-11-01
err138
errOAAI
errMacor, Paolo; Tripodo, Claudio; Zorzet, Sonia; Piovan, Erich; Bossi, Fleur; Marzari, Roberto; Amadori, Alberto; Tedesco, Francesco
err分享
err收藏
学者 查看更多内容